-
Verteporfin Beyond PDT: A Mechanobiology Framework
2026-09-12
Verteporfin and CL 318952 can be interpreted through a mechanobiology lens that separates light-dependent cytotoxicity, autophagy inhibition, and cancer-cell stiffness. This guide connects Verteporfin assay design with the MRTFA–KCNMB1 findings that link ionic regulation to metastatic immune evasion.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-09-11
A 2026 FASEB Journal study developed chemically modified p21 mRNA packaged in lipid nanoparticles for catheter-based bladder delivery. The approach restored nuclear p21, inhibited tumor-cell proliferation, and reduced orthotopic bladder tumor growth while limiting systemic exposure, supporting localized tumor suppressor replacement as a translational strategy.
-
KN-62: A Causal CaMKII Assay Design Guide
2026-09-11
KN-62 is a selective CaMKII inhibitor for separating kinase-dependent signaling from upstream calcium-channel effects. This guide combines product chemistry, secretion and metabolism data, cell-cycle biology, and a calcium-channel reference study to build more discriminating assays.
-
Firefly Luciferase mRNA: Assay Workflows
2026-09-10
Build more reproducible transfection, gene expression, and cell viability workflows with a modified, ARCA-capped luciferase transcript. This guide connects practical assay setup with delivery lessons from recent mRNA vaccine research, while clearly separating validated product characteristics from optimization recommendations.
-
Nelfinavir Mesylate: Two-Pathway Assay Logic
2026-09-10
Nelfinavir Mesylate is more than an HIV-1 protease inhibitor: it is a useful probe for separating antiviral activity from DDI2-NFE2L1 control of ferroptosis. This guide presents a causality-focused assay framework for HIV replication suppression, proteostasis analysis, and HIV infection research.
-
AG-490 (JAK2/EGFR inhibitor) Assay Guide
2026-09-09
This scenario-based guide explains how AG-490 (JAK2/EGFR inhibitor), SKU A4139, can support controlled studies of JAK-STAT, EGFR, and MAPK signaling in viability, proliferation, and cytotoxicity workflows. It connects formulation, dose interpretation, exosomal SNORD52 research, and practical vendor-selection criteria without overstating pathway-specific evidence.
-
Dorsomorphin (Compound C): AMPK Assay Logic
2026-09-09
Dorsomorphin (Compound C) is more than an AMPK inhibitor: it is a useful perturbation tool for testing pathway causality in endothelial stress, metabolic, autophagy, and BMP studies. This guide explains how to interpret Compound C experiments, select orthogonal readouts, and avoid confusing pathway association with mechanism.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-09-08
The reference study shows that puerarin enhances osteogenic differentiation of rat dental follicle cells while increasing nitric oxide, cGMP, and related osteogenic markers. Pharmacological inhibition with L-NMMA reversed these effects, supporting a functional role for nitric oxide signaling in a periodontal regeneration model.
-
Predictive siRNA Codelivery with Netarsudil
2026-09-08
Slaughter and colleagues developed a quantitative screening and machine-learning framework for predicting when ionizable drugs can complex siRNA and support nanoparticle encapsulation. Netarsudil was identified as a high-performing candidate and experimentally evaluated with CTGF-targeting siRNA in fibrotic human trabecular meshwork cells, linking drug-enabled delivery with cytoskeletal and gene-expression readouts.
-
Gramine Workflow for Ferroptosis and TNBC Research
2026-09-07
Gramine provides a mechanism-oriented way to connect TNBC growth inhibition with ferroptosis and the CUL3–MTDH ubiquitination axis. This practical workflow combines dose-response screening, rescue experiments, target-engagement assays, and biomarker validation for reproducible cancer biology research.
-
Light-Inducible RNA Release in Gene Therapy
2026-09-07
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage rather than through transcription alone. In mouse models, LIRP-regulated AAV systems used daylight, darkness, or selective blue-light filtering to modulate metabolic and retinal gene therapies, illustrating a potential safety advantage for on-demand treatment.
-
Bestatin (Ubenimex) Aminopeptidase Workflows
2026-09-05
Bestatin (Ubenimex) turns selective aminopeptidase inhibition into a practical probe for enzyme assays, MDR research, apoptosis assay design, cancer research, and plant chemical genetics. This guide links potency-aware assay setup with controls, troubleshooting, and the Arabidopsis jasmonate-signaling discovery that expanded Bestatin’s value beyond conventional protease studies.
-
Direct Mouse Genotyping Kit: From Genotype to Mechanism
2026-09-04
Rapid tissue-to-PCR workflows can do more than accelerate colony management: they can help translational researchers connect engineered alleles with molecular mechanisms. This article examines how direct mouse genotyping supports mechanistic studies inspired by scaRNA1-dependent U2 pseudouridylation and defines the workflow boundaries that matter for rigorous model development.
-
How Translatome Remodeling Links Diet to Tumorigenesis
2026-09-04
Yang and colleagues show that fasting does not simply suppress hepatic protein synthesis: it selectively remodels translation through the AMPK–MNK–phosphorylated eIF4E axis. This mechanism enables ketogenesis and creates a diet-dependent vulnerability in pancreatic tumors, offering a framework for studying how fatty-acid signals reshape protein production.
-
Substance P: An Assay-Centered Research Framework
2026-09-03
Substance P research requires more than receptor activation: matrix effects, sample handling, and readout quality can determine whether a biological signal is interpretable. This assay-centered framework connects tachykinin biology with rigorous analytical decision-making while clarifying how fluorescence preprocessing concepts can—and cannot—transfer to peptide experiments.